SCHEMBL30830490

SCHEMBL30830490

O=C1CCC(N2CCC(N3CCNCC3)CC2)C(=O)N1

nearest known ligand 0.48

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
CRBN Q96SW2 14/20 0.48
DDB1 Q16531 9/20 0.43
ALDH1A1 P00352 2/20 0.42
TDP1 Q9NUW8 2/20 0.42
CHRM2 P08172 1/20 0.42
OPRM1 P35372 1/20 0.42
IKZF3 Q9UKT9 1/20 0.42
CYP1A2 P05177 1/20 0.42
TSHR P16473 1/20 0.42
TNF P01375 1/20 0.41
KDM4E B2RXH2 1/20 0.40
MEN1 O00255 1/20 0.40
APEX1 P27695 1/20 0.40
KMT2A Q03164 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
IKZF2 Q9UKS7 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20812035 0.92 CRBN (0.54) CRBNDDB1ALDH1A1TDP1CHRM2
Hydrochloric Acid SCHEMBL19585786 0.90 CRBN (0.53) CRBNDDB1ALDH1A1TDP1CHRM2
Water SCHEMBL28335951 0.90 CRBN (0.53) CRBNDDB1ALDH1A1TDP1CHRM2
Trifluoroacetic Acid SCHEMBL31630885 0.80 CRBN (0.46) CRBNDDB1ALDH1A1TDP1CHRM2
SCHEMBL20463179 0.79 CRBN (0.43) CRBNDDB1ALDH1A1TDP1CHRM2
SCHEMBL20812349 0.78 CRBN (0.57) CRBNDDB1ALDH1A1TDP1CHRM2
SCHEMBL20812624 0.78 CRBN (0.57) CRBNDDB1ALDH1A1TDP1CHRM2
SCHEMBL19359470 0.76 CRBN (0.56) CRBNDDB1ALDH1A1TDP1CHRM2
SCHEMBL30817357 0.76 CRBN (0.49) CRBNDDB1ALDH1A1TDP1CHRM2
Trifluoroacetic Acid SCHEMBL31630914 0.76 CRBN (0.42) CRBNDDB1ALDH1A1TDP1CHRM2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4581025-A1 PYRIDAZINON DERIVATIVES AS KAT2 DEGRADERS FOR THE TREATMENT OF PROLIFERATIVE DISORDERS Auron Therapeutics, Inc. (US) 2025-07-09 EP disclosed
WO-2024050078-A1 PYRIDAZINON DERIVATIVES AS KAT2 DEGRADERS FOR THE TREATMENT OF PROLIFERATIVE DISORDERS AURON THERAPEUTICS, INC. (US) 2024-03-07 WO disclosed